Olanzapine Injection, Powder, Lyophilized, For Solution
Product Images NDC 68462-952

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 68462-952). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

This text provides detailed information about the medication Olanzapine for injection in a single-dose vial. It includes instructions for intramuscular use, reconstitution with sterile water, dosage, and administration. The vial contains 10 mg of Olanzapine and lists inactive ingredients like lactose and tartaric acid. There are storage guidelines both before and after reconstitution, emphasizing the need to use the solution within one hour of mixing. The vial should be stored at controlled room temperature and protected from light. The product is distributed by Glenmark Pharmaceuticals Inc. in the USA.*

FDA Label Image

Logo (Logo)

This text is not readable.*

FDA Label Image

"image Description" (Olanzapine Injection Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.